Zacks Investment Research
16 Jul 2026, 22:52 UTC · 1h ago
Freeport-McMoRan (FCX) Declines More Than Market: Some Information for Investors
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
16 Jul 2026, 22:52 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Freeport-McMoRan's consensus EPS estimate has increased by 6.76% over the last 30 days. — Positive analyst estimate revisions typically correlate with upward stock price movement.
+0.30Freeport-McMoRan is expected to report an EPS of $0.6 on July 23, 2026, representing an 11.11% increase from the prior-year quarter. — Expected growth in quarterly earnings is generally a positive catalyst for the share price.
+0.20Freeport-McMoRan's expected quarterly revenue of $6.47 billion represents a 14.61% decrease compared to the same quarter last year. — A double-digit decline in year-over-year revenue suggests a contraction in top-line growth.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Freeport-McMoRan (FCX) closed the most recent trading day at $58.56, a decline of 3.95%. — Immediate price action shows short-term bearish momentum and underperformance relative to the S&P 500.
Which stocks this story touches
The stock closed down 3.95% and has recently lagged behind the S&P 500, though future earnings estimates show some growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
